Bone News and Research

RSS

BioMimetic Therapeutics annouces completion of Augment Bone Graft PMA submission

BioMimetic Therapeutics, Inc. today announced it has submitted the third and final module of its Premarket Approval (PMA) application for marketing of Augment™ Bone Graft in the U.S. This final module, containing a comprehensive review of the clinical data related to Augment, completes the PMA application to the FDA. The Company previously announced the filing of both the pre-clinical pharmacology/toxicology and quality/manufacturing modules with the FDA in June of 2009.

18 Feb 2010

BrainStorm Cell Therapeutics secures funds for ALS clinical trials

BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that it has entered into agreements with three investors with each investing $500,000 for a total of investment of $1.5 million into BrainStorm.

18 Feb 2010

Genzyme announces fourth-quarter and full-year 2009 financial results

Genzyme Corp., a diversified, global biotechnology company, today announced fourth-quarter and full year 2009 financial results and provided 2010 guidance that reflects growth across its businesses and a focus on strengthening core areas of the company.

18 Feb 2010

Athersys completes enrollment in phase I MultiStem allogeneic stem cell therapy clinical trial

Athersys, Inc. and Angiotech Pharmaceuticals, Inc. announced that Athersys has completed patient enrollment for its phase I clinical trial of MultiStem(R), its allogeneic stem cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as a heart attack. Top line results of the trial are expected to be announced midyear, upon completion of the four-month patient follow-up visits and analysis of results.

17 Feb 2010

SBi introduces 10-minute new surgical technique DVD for hand surgeons

Small Bone Innovations, Inc., a leading, privately-held orthopedics company focused exclusively on technologies and treatments for the small bones & joints, is making available to hand surgeons a new 10-minute new surgical technique DVD showing an innovative volar approach to insertion of its SR™ PIP (Proximal Interphalangeal) implant.

17 Feb 2010

Novel composite foam could lead to new generation of biomedical implants

A "metal foam" that has a similar elasticity to bone could mean a new generation of biomedical implants that would avoid bone rejection that often results from more rigid implant materials, such as titanium.

17 Feb 2010

FDA approves risk management program on ESA's for treating anemia due to chemotherapy

The U.S. Food and Drug Administration today approved a risk management program to inform healthcare providers and their patients about the risks of a class of drugs called Erythropoiesis-Stimulating Agents (ESAs). For patients with cancer, the program is also designed to help ensure the appropriate administration of these drugs, which they receive to treat anemia that can occur as a result of chemotherapy.

17 Feb 2010

Generx clinical development opportunities: bioRASI to assist Cardium

Cardium Therapeutics today announced that it has entered into an agreement with bioRASI, an international contract research organization, to assist Cardium in the evaluation of Generx clinical development opportunities within major newly-industrializing markets in Eastern Europe, Asia and Latin America, for patients with chronic coronary artery disease who are either not optimal candidates for or do not have access to costly angioplasty/stenting or cardiac bypass surgery procedures.

17 Feb 2010

Osseon Therapeutics completes first Osseoplasty procedures in Europe

Osseon Therapeutics Inc. today announced it has completed its first Osseoplasty™ procedures in Europe. The procedures were performed in Milan, Italy.

17 Feb 2010

New research report on orthopedic biomaterials market in the U.S.

According to a new global report series by iData Research (www.idataresearch.net), the leading authority in medical device, dental and pharmaceutical market research, the U.S. market for orthopedic biomaterials grew by 11.5% in 2009 and is estimated to reach almost $6.3 billion by 2016.

17 Feb 2010

Special issue reviews current state of science in fetal therapy

Repairing birth defects in the womb. Inserting a tiny laser into the mother's uterus to seal off an abnormal blood flow and save fetal twins. Advancing the science that may allow doctors to deliver cells or DNA to treat sickle cell anemia and other genetic diseases before birth.

17 Feb 2010

Merck announces global sales of $27.4 billion for full-year 2009

Merck & Co., Inc. today announced financial results for the fourth quarter and the full year of 2009 which include the results of legacy Schering-Plough operations from the close of the merger on Nov. 3, 2009 through Dec. 31, 2009.

16 Feb 2010

Scientists discover molecular pathway to regenerate damaged kidney tissues

Scientists have discovered a molecular pathway that works through the immune system to regenerate damaged kidney tissues and may lead to new therapies for repairing injury in a number of organs.

16 Feb 2010

AstraZeneca, Rigel Pharmaceuticals announce exclusive worldwide license agreement for R788

AstraZeneca and Rigel Pharmaceuticals today announced an exclusive worldwide license agreement for the global development and commercialization of fostamatinib disodium (R788), Rigel's late-stage investigational product for rheumatoid arthritis (RA) and additional indications.

16 Feb 2010

Bone-anchored hearing aids appear to be durable treatment option for single-sided deafness

Surgically implanted hearing aids anchored to the skull bone appear to be a durable treatment option that noticeably improves hearing among children with deafness in one ear, according to a report in the February issue of Archives of Otolaryngology -- Head & Neck Surgery, one of the JAMA/Archives journals.

16 Feb 2010

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

The new decade may herald an era of cell therapy -- treating human diseases by delivering highly specific beneficial cells. In the wake of an NIH decision late last year permitting federally funded researchers to use new lines of human embryonic stem cells, the door has opened more widely to stem cell research.

16 Feb 2010

Stematix enters into 10-year exclusive agreement with Laboratorios Bagó SA

Stematix, Inc. (Houston, USA), a regenerative medicine provider positioned to accelerate safe and effective global use of stem cell therapies, announced today that it entered into a 10-year exclusive agreement with Laboratorios Bagó (Buenos Aires, Argentina), a leading Argentine medical products company.

15 Feb 2010

Fast method for producing bone and cartilage tissue using body's own cells

Injuries to joints and cartilage can have serious consequences, including osteoarthritis. Cartilage degeneration in joints is a widespread disease in Germany and worldwide. Prof. Dr. Prasad Shastri is an expert in tissue engineering (TE), tissue construction and tissue cultivation using the body's own cells. He is Professor of Biofunctional Macromolecular Chemistry at the Centre for Biological Signalling Studies (BIOSS), a Cluster of Excellence at the University of Freiburg, where he has been researching for the last year.

15 Feb 2010

Bacterin International completes $3M private placement of Secured Convertible Promissory Notes

Bacterin International, Inc. (Bacterin), a developer of biological scaffolds for orthopedic indications, today announced the completion of a $3 million private placement of Secured Convertible Promissory Notes led by Middlebury Securities, LLC.

14 Feb 2010

Transition through hemogenic endothelial intermediate necessary for hematopoietic stem cell formation

Biologists at UC San Diego have identified the specific region in vertebrates where adult blood stem cells arise during embryonic development.

14 Feb 2010

Bone News and Research

BioMimetic Therapeutics annouces completion of Augment Bone Graft PMA submission

BrainStorm Cell Therapeutics secures funds for ALS clinical trials

Genzyme announces fourth-quarter and full-year 2009 financial results

Athersys completes enrollment in phase I MultiStem allogeneic stem cell therapy clinical trial

SBi introduces 10-minute new surgical technique DVD for hand surgeons

Novel composite foam could lead to new generation of biomedical implants

FDA approves risk management program on ESA's for treating anemia due to chemotherapy

Generx clinical development opportunities: bioRASI to assist Cardium

Osseon Therapeutics completes first Osseoplasty procedures in Europe

New research report on orthopedic biomaterials market in the U.S.

Special issue reviews current state of science in fetal therapy

Merck announces global sales of $27.4 billion for full-year 2009

Scientists discover molecular pathway to regenerate damaged kidney tissues

AstraZeneca, Rigel Pharmaceuticals announce exclusive worldwide license agreement for R788

Bone-anchored hearing aids appear to be durable treatment option for single-sided deafness

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

Stematix enters into 10-year exclusive agreement with Laboratorios Bagó SA

Fast method for producing bone and cartilage tissue using body's own cells

Bacterin International completes $3M private placement of Secured Convertible Promissory Notes

Transition through hemogenic endothelial intermediate necessary for hematopoietic stem cell formation

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News